We used a 7-stage protocol to generate beta cells from human Induced Pluripotent Stem Cells (iPSC) and evaluated whether these cells are responsive to the pro-inflammatory cytokines (IFNγ, IL-1β, or IFNα) that play a role in type 1 diabetes (T1D). Our data show that human iPSC-derived beta cells
Last updated on: 09-03-2021 - 21:30
Contact: Decio L. Eizirik
Organisation: Université Libre de Bruxelles (ULB), Indiana Biosciences Research Institute
Status: Published in peer reviewed journal
